AAV5-RPGR (botaretigene sparoparvovec) gene therapy for X-linked retinitis pigmentosa (XLRP) demonstrates localized improvements in static perimetry-MedSci.cn

AAV5-RPGR (botaretigene sparoparvovec) gene therapy for X-linked retinitis pigmentosa (XLRP) demonstrates localized improvements in static perimetry

Michaelides, M; Xu, JL; Wang, D; Wong, P; Fung, A; Forbes, A; Naylor, S; Zeldin, R; Parker, MA; Weleber, R; de Guimaraes, TAC; Besirli, C; Yang, Y; Bainbridge, J

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022; 63 (7):

科室
- - 订阅+
  - 更多科室
工具
服务